与tiotropium相关的不良药物事件:FDA不良事件报告系统数据库的现实世界药监测研究
Yang Rui1, Tianyuan Xin1, Yu Chen1
1Laboratory of Cough, Kunshan Key Laboratory of Chronic Cough, Affiliated Kunshan Hospital of Jiangsu University, Suzhou, China.
概括
这项研究分析了FAERS中tiotropium的不良事件,确定了呼吸障碍和肺炎等常见问题. 发现了新的安全信号,包括罕见的癌症,促使医生意识到这种COPD和喘药物的安全处方.
科学领域:
- 药监和药物安全性分析.
- 呼吸系统医学和制药研究.
背景情况:
- 铁是COPD和喘的关键维持治疗方法.
- 在临床试验之外的真实世界的安全数据对于tiotropium至关重要.
- 营销后监测对于识别罕见不良事件至关重要.
研究的目的:
- 使用FAERS数据库分析与tiotropium相关的不良事件 (AE).
- 为了确定的潜在安全信号和以前未报告的副作用.
- 为了更好地理解tiotropium在现实世界的安全性.
主要方法:
- 在FAERS数据库 (2004-2024) 中对tiotropium报告的回顾性分析.
- 使用MedDRA (v27.1) 对AE的系统分类首选术语和系统器官类别.
- 使用ROR,PRR,BCPNN和MGPS来检测安全信号的不成比例分析.
主要成果:
- 分析了129,763份涉及65,045名患者的AE报告.
- 最常见的副作用:呼吸不全 (8600),咳 (2440),肺炎 (2080).
- 信号强度最高的副作用是:呼吸不全加重 (ROR 162.04),声 (ROR 43.42),慢性肺炎加重 (ROR 43.17).
- 发现了潜在的新风险:表层癌症,光环视觉,恶性肺瘤.
结论:
- 这项研究确定了与tiotropium相关的新型不良反应.
- 医生在开药时应考虑这些新发现的副作用.
- 加强药物监测对于全面的药物安全评估至关重要.
相关概念视频
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:29Therapeutic Drug Monitoring: Affecting Factors
202
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
202
01:16Therapeutic Drug Monitoring: Overview and Classification
312
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
312
01:26FDA Approved Drugs: Changes to Approved Drugs
245
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
245
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
180
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
180
01:24Cholinergic Antagonists: Pharmacokinetics
905
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
905